TY  - GEN
AU  - Li,Gaopeng
AU  - Dong,Shengli
AU  - Qu,Junyuan
AU  - Sun,Zhengang
AU  - Huang,Zhiyong
AU  - Ye,Lu
AU  - Liang,Huifang
AU  - Ai,Xi
AU  - Zhang,Wanguang
AU  - Chen,Xiaoping
TI  - Synergism of hydroxyapatite nanoparticles and recombinant mutant human tumour necrosis factor-alpha in chemotherapy of multidrug-resistant hepatocellular carcinoma
SN  - 1478-3231
PY  - 2010///0811
KW  - Animals
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Apoptosis
KW  - drug effects
KW  - Blotting, Western
KW  - Carcinoma, Hepatocellular
KW  - drug therapy
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - Disease Models, Animal
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Drug Resistance, Multiple
KW  - Drug Resistance, Neoplasm
KW  - Drug Synergism
KW  - Durapatite
KW  - pharmacology
KW  - Female
KW  - Genes, MDR
KW  - Humans
KW  - Liver Neoplasms
KW  - Mice
KW  - Mice, Inbred BALB C
KW  - Multidrug Resistance-Associated Proteins
KW  - Neoplasms, Experimental
KW  - Probability
KW  - RNA, Messenger
KW  - metabolism
KW  - Random Allocation
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - Tumor Necrosis Factor-alpha
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1478-3231.2009.02113.x
ER  -